u/declared_value_dv

That is Scotland’s arrangement and the post is asking about England.

the interesting data is the combination, not the monotherapy

do not assume reconstitution intuitions apply, there is nothing to reconstitute

Why the monthly pricing tracker works, and the rule that makes it work.

Members post the pharmacy, the product, the month and the price they actually paid — not an advertised offer, not a first-month discount. No links of any kind are permitted, which removes the entire incentive to post anything other than what happened.

The result is that the spread between pharmacies in a given month is visible, and it is consistently larger than people expect. That single table has saved members here more money than every other thread on the board combined, and it survives only because the no-links rule is enforced without exception.

Daily dosing, so what does the exposure profile look like across the day?

Country added to the title. Without it the answers will be confidently wrong.

That is the first-month offer price, not the ongoing monthly cost. The tracker records the second one.

the ICB decides the threshold and they are not the same across England

Correcting myself: the referral was 10 months ago, not the figure I gave. I keep rounding it down.

I keep a laminated card in the drawer with the arithmetic on it. Looks ridiculous. Has never once let me draw the wrong volume.

The failure modes I have actually seen posted here, in order of frequency.

One: reconstituting at a different volume than intended and not writing it down, so the next draw is based on a remembered concentration. Two: treating units as a dose rather than a volume, which breaks the moment the concentration changes. Three: assuming a syringe is U-100 when it is not.

All three are solved by the same two habits — do the arithmetic before the water goes in, and write the result on the glass. Neither costs anything and between them they cover almost every question this board gets.

Why "more water" keeps confusing people, including me for a month.

The vial contains a fixed amount of peptide. Water changes nothing about that amount. What it changes is concentration, and concentration is the divisor between the dose you want and the volume you draw.

So doubling the water halves the concentration and doubles the units for the same dose. Nothing is diluted in any sense that matters; you are simply reading a bigger number off the same barrel. Pick the water volume that puts your usual dose on a whole number of units and life gets easier.

Milligram-for-milligram comparison with an injectable peptide is not meaningful and I should not have made it.

How many mg in the vial and how many mL are you adding?

Right, and reading the actual supply notice rather than the coverage of it saves a fortnight of speculation.

Correction: that gives 20 units, not what you have written. 15mg into 2mL is 7.5mg/mL and the division follows from there.

Careful — that guidance is several years old and the rules where you are have moved since.

Agreed — read the notice before deciding what has happened. Most of the panic here is misclassification.

Country added to the title. Without it the answers will be confidently wrong.

the powder cake sits at the bottom, the volume you add is the volume that counts

Show the arithmetic — where did the unit figure come from?

Address redacted from the screenshot above. Post the wording of the notice, never the header.

phase 3 data will change most of what gets said here

research-use-only labelling is not a customs category

Country added to the title. Without it the answers will be confidently wrong.

the boards keep comparing it to injectables at matched doses, which is meaningless

twice as much water halves the concentration and doubles the units for the same dose

What is written on the vial right now?

Agreed. The ICB variation is the thing that makes national advice useless here.

Milligram-for-milligram comparison with an injectable peptide is not meaningful and I should not have made it.

the co-agonism argument is about complementary mechanisms

NHS pathway or private prescription?

a hold is not a seizure and people conflate them constantly

Adding the standing caveat — nothing here is legal advice and this one genuinely warrants somebody qualified.

Discharge at goal, which nobody warns people about.

Specialist services in England are commissioned to deliver a defined intervention. Reaching goal is a successful outcome and it typically ends with discharge back to primary care. Whether prescribing continues after that is a local decision that varies, and plenty of members here have discovered it at the point of discharge rather than at the start.

The useful thing to do is ask early: what happens when I finish, and does prescribing continue in primary care in this area. Ask it in writing, keep the answer, and you will at least know which conversation you are heading for.

A private prescription is an independent route: it does not affect NHS list position, and it is not a step in the same pathway.

Small fix — that is the Scottish pathway. The post is asking about England and the answer is different.

do not assume the dosing intuitions from the GLP-1 boards transfer

Yes. Writing 5mg/mL on the vial takes four seconds and removes the entire class of error this board exists to fix.